Juvenile xanthogranuloma: forms of systemic disease and their clinical implications.

Freyer, D R; Kennedy, R; Bostrom, B C; Kohut, G; Dehner, L P

Freyer, D R; Kennedy, R; Bostrom, B C; Kohut, G; Dehner, L P.

Affiliation

Freyer DR; Department of Pediatrics, DeVos Children's Hospital, Grand Rapids, Michigan 49503, USA.

J Pediatr ; 129(2): 227-37, 1996 Aug.

Article in En | MEDLINE | ID: mdl-8765620

Subject(s)

Xanthogranuloma, Juvenile/pathology; Anti-Inflammatory Agents/administration & dosage; Anti-Inflammatory Agents/therapeutic use; Brain Diseases/pathology; Child; Child, Preschool; Cyclosporine/administration & dosage; Cyclosporine/therapeutic use; Etoposide/administration & dosage; Etoposide/therapeutic use; Humans; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/therapeutic use; Infant; Infant, Newborn; Liver Diseases/pathology; Lung Diseases/pathology; Male; Prednisone/administration & dosage; Prednisone/therapeutic use; Remission, Spontaneous; Skin/pathology; Splenic Diseases/pathology; Survival Rate; Treatment Outcome; Vinblastine/administration & dosage; Vinblastine/therapeutic use; Xanthogranuloma, Juvenile/physiopathology; Xanthogranuloma, Juvenile/surgery; Xanthogranuloma, Juvenile/therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Xanthogranuloma, Juvenile Limits: Child / Child, preschool / Humans / Infant / Male / Newborn Language: En Journal: J Pediatr Year: 1996 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links